Confounding Factors in Renal Denervation Trials
Identification
- Public canonical key
- doi:10.1161/hypertensionaha.120.15745
- Authors
- David E. Kandzari · Felix Mahfoud · Deepak L. Bhatt · Michael Böhm · Michael A. Weber · Raymond R. Townsend · Douglas A. Hettrick · Roland Erich Schmieder · Konstantinos P Tsioufis · Kazuomi Kario
- Reported year
- 2020
- Reported language
- en
- Source type
- review
- First detected
- 2026-11-09T19:16:01.594903+00:00
- Last metadata observation
- 2026-11-09T19:16:01.594903+00:00
- Last HTTP verification
- Not checked
Institutions reported by the source
Athens Medical Center · Brigham and Women's Hospital · Harvard University · Jichi Medical University · National and Kapodistrian University of Athens · Piedmont Atlanta Hospital · SUNY Downstate Health Sciences University · Saarland University · State University of New York · University of Pennsylvania · Universitätsklinikum Erlangen · Universitätsklinikum des Saarlandes
Documentary abstract — original language
Recent randomized sham-controlled trials have demonstrated significant blood pressure reductions following renal denervation (RDN) in patients with hypertension, both in the presence and absence of antihypertensive therapy. These new data encouraged us to revisit previously published insights into potential clinical trial confounding factors that informed the design and conduct of forthcoming trials. Initially identified confounders related to procedural technique, medication variability, and selected patient subgroups have been addressed in contemporary trial design. Regarding procedural method and technology, blood pressure reductions may be improved by ensuring circumferential lesion creation in the distal renal arteries and branch vessels. Safety of the RDN procedure has been demonstrated in multiple independent meta-analyses including thousands of treated patients with low reported rates of renal vessel complications and maintenance of renal function. However, a newer generation of RDN trials has also introduced insights related to medication adherence, patient selection, and the definition of treatment response. Evolving evidence indicates that RDN therapy may be considered in higher risk populations of uncontrolled hypertension regardless of ethnicity and in patients expressing a strong preference for a nondrug therapy option. Despite advances in procedural technique and clinical trial conduct, inconsistent antihypertensive-drug adherence behavior remains perhaps the most critical clinical trial design issue for device-based hypertension therapies. As the balance in clinical equipoise increasingly favors RDN, justification of sham-controlled trial designs will be revisited, and novel study designs may be required to evaluate the safety and efficacy of novel devices and procedures intended to address the escalating prevalence of poorly controlled hypertension.
Identifiers
- OPENALEX
- W3087999951
- DOI
- 10.1161/hypertensionaha.120.15745
Documentary context
- Documentary family
- Scholarship
- Source-reported types
- review
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1 · Record 2
Documented bibliographic relations
Source-declared references and links; they do not establish legal support or UGLC qualification. Up to 20 outgoing references are displayed.
- openalex:w1583834060 · CITES
- openalex:w1852036889 · CITES
- openalex:w1973575835 · CITES
- openalex:w2002879082 · CITES
- openalex:w2010972994 · CITES
- openalex:w2058618570 · CITES
- openalex:w2084076051 · CITES
- openalex:w2106464972 · CITES
- openalex:w2115136352 · CITES
- openalex:w2115461708 · CITES
- openalex:w2133088349 · CITES
- openalex:w2150305971 · CITES
- openalex:w2152487583 · CITES
- openalex:w2170379141 · CITES
- openalex:w2193371298 · CITES
- openalex:w2343833096 · CITES
- openalex:w2397519623 · CITES
- openalex:w2435193784 · CITES
- openalex:w2492725378 · CITES
- openalex:w2510212662 · CITES
1 incoming references within the detected corpus
Documentary field provenance
Source-backed values and values with unresolved provenance are kept separately. Bibliographic provenance validates no legal claim.
- Title
- Documentary source reported
- Publication
- Documentary source reported
- Authors
- Documentary source reported
- Document type
- Documentary source reported
- Jurisdiction
- Not recorded
- Court
- Not recorded
- Issuing authority
- Not recorded
- Publisher
- Not recorded
- DOI
- Documentary source reported
- ISBN
- Not recorded
- Official identifier
- Not recorded
- Source URL
- Documentary source reported
- Source-reported status
- Not recorded
- Amendment / repeal
- Not recorded
Cite this reference
David E. Kandzari; Felix Mahfoud; Deepak L. Bhatt; Michael Böhm; Michael A. Weber; Raymond R. Townsend; Douglas A. Hettrick; Roland Erich Schmieder; Konstantinos P Tsioufis; Kazuomi Kario. Confounding Factors in Renal Denervation Trials. 2020. https://doi.org/10.1161/hypertensionaha.120.15745
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- David E. Kandzari; Felix Mahfoud; Deepak L. Bhatt; Michael Böhm; Michael A. Weber; Raymond R. Townsend; Douglas A. Hettrick; Roland Erich Schmieder; Konstantinos P Tsioufis; Kazuomi Kario. (2020). Confounding Factors in Renal Denervation Trials. https://doi.org/10.1161/hypertensionaha.120.15745
- Chicago
- David E. Kandzari; Felix Mahfoud; Deepak L. Bhatt; Michael Böhm; Michael A. Weber; Raymond R. Townsend; Douglas A. Hettrick; Roland Erich Schmieder; Konstantinos P Tsioufis; Kazuomi Kario. Confounding Factors in Renal Denervation Trials. 2020. https://doi.org/10.1161/hypertensionaha.120.15745
- ISO 690
- David E. Kandzari; Felix Mahfoud; Deepak L. Bhatt; Michael Böhm; Michael A. Weber; Raymond R. Townsend; Douglas A. Hettrick; Roland Erich Schmieder; Konstantinos P Tsioufis; Kazuomi Kario. Confounding Factors in Renal Denervation Trials. 2020. https://doi.org/10.1161/hypertensionaha.120.15745
UDTR Global Rights of Nature Legal Library. Confounding Factors in Renal Denervation Trials. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-c4145d40163c5fa9fa4180fc55e93269/ · Last HTTP verification: not performed
Field provenance and record version
Version b1899ab969d0cb8a · udtr-reference-1.1.2
- Title
- OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
- Authors
- OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
- Year
- OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
- Identifiers
- OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
- Source URL
- OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
- Source-reported author ORCID
- OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
OpenAlex · source · 2026-11-09T19:16:01.594903+00:00
History tracks record metadata and does not certify the state of the law.
d5ba3b3738b84b7f · 2026-11-09T19:16:01.594903+00:00
fd8f2cb263d9c410 · 2026-11-09T19:16:01.594903+00:00
ec72f111fbeb9ff7 · 2026-11-09T19:16:01.594903+00:00
b1899ab969d0cb8a · 2026-11-09T19:16:01.594903+00:00
Research dossiers and documentary relations
National and Kapodistrian University of Athens
SUNY Downstate Health Sciences University
Universitätsklinikum des Saarlandes
Source roles
Discovery source · https://doi.org/10.1161/hypertensionaha.120.15745
Discovery source · https://openalex.org/W3087999951
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.